HAYWARD, Calif.--(BUSINESS WIRE)--Eikon Therapeutics, Inc., a clinical stage biotechnology company that is advancing breakthrough therapeutics through the purposeful integration of engineering and ...
- Robert Blaustein, M.D., Ph.D. appointed as Chief Development Officer (CDO) - BOULDER, Colo.--(BUSINESS WIRE)--Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading ...
- Company is on track to initiate its global Phase 3 pivotal program for CYB003 in Major Depressive Disorder (“MDD”) imminently - - Cybin welcomes Dr. Mirza Rahman as Senior Vice President, Patient ...
VANCOUVER, British Columbia, April 21, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to ...
LOWELL, Mass., Sept. 11, 2024 /PRNewswire/ -- Versatope Therapeutics Incorporated, a biotechnology company developing vaccines and immuno-therapeutics announced today their new Chief Medical Officer, ...
Tryptamine strengthens clinical development team with two key appointments Professor Marcel Mozafari appointed senior formulation scientist and Professor David Castle appointed consultant medical ...
Under the leadership of Roy Baynes, experienced team of industry veterans is poised to successfully move assets through clinical development and regulatory review “In support of our vision to build a ...
Zymeworks Inc. announced the appointment of Dr. Sabeen Mekan as Senior Vice President of Clinical Development, where she will play a critical role in shaping the company's clinical strategy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback